"The practice of medicine is changing from a reactive approach to
treating disease, to one that is more proactive and preventive," said
Using LC-MS technology, clinical laboratories perform qualitative and quantitative analyses of patients' samples to aid clinicians in many ways. These tests may be used to confirm a clinical suspicion (including making a diagnosis); assist in the selection, optimization and monitoring of treatment; provide a prognosis; screen for disease in the absence of clinical signs or symptoms; and establish and monitor the severity of physiological disturbance. Liquid chromatography separates analytes and interferents within a given sample, while mass spectrometry technology is used for detection and confirmation of those analytes.
The recently CFDA approved ACQUITY UPLC I-Class IVD/Xevo TQ-S IVD System features Waters' UltraPerformance LC® technology coupled with a tandem quadrupole mass spectrometer designed for the most demanding UPLC-MS/MS quantitative analysis. This system uses StepWave™, a breakthrough off-axis ion source technology, and RADAR™, an information rich acquisition method, enabling the system with sensitivity and robustness.
For more information, please visit Waters' Clinical application page.
For over 50 years,
As a pioneer in separation science, laboratory information management, mass spectrometry, and thermal analysis technology, Waters has created a sustainable platform with its technical breakthroughs and laboratory solutions for the success of its clients.
Waters achieved revenues of
Waters, ACQUITY, ACQUITY UPLC, UPLC, XEVO, StepWave and RADAR are
Jeff Tarmy, 508-482-2268